How chronic pain is treated: movement, mind–body skills, and why there's no single fix
If you searched for chronic pain physical therapy treatment, the honest answer is that the strongest plans are multimodal, not a single pill or procedure.

Short answer
The strongest chronic pain treatment plans are multimodal, not a single pill or procedure. Modern care is built around movement and physical therapy paced to your tolerance, plus mind–body skills such as CBT or ACT. Medication can be part of it, chosen by a clinician. Opioids are not first-line for long-term non-cancer pain.
If you have been told the scans look fine and the pain should have stopped by now, you were not imagining it. Chronic pain is a condition in its own right, not evidence that you are exaggerating, not a failure to cope, and not something you should be able to push through by trying harder. The reason one treatment rarely fixes it is the same reason it is real: it involves several systems at once.
Note: this article describes how chronic pain is treated in general and is not medical advice. Which treatment fits you depends on your diagnosis, health history and risks, and that judgment belongs to a clinician. New, sudden, or rapidly changing pain needs assessment rather than a management plan.
Why one treatment is rarely enough
Chronic pain usually sits in a loop between the nervous system, muscles, sleep, stress, mood, daily load, and fear of flare-ups, so a plan that only turns one dial often leaves the rest of the loop untouched. Modern care therefore builds around movement and physical therapy delivered by tolerance, pacing your activity, and mind–body skills such as CBT or ACT. Medication can still be part of care, but only as a clinician-selected class matched to your pain type, health history, risks, and goals — not as a self-directed fix. Opioids are not a routine first-line treatment for long-term non-cancer pain; CDC guidance says nonopioid therapies are preferred for subacute and chronic pain, and NICE recommends exercise and selected psychological therapies for chronic primary pain while advising against starting opioids for chronic primary pain. In Welltory's own data, users who self-report chronic pain (n = 1,151) carry a heavier overall symptom-and-comorbidity load than other users, yet a single morning HRV or readiness score reads essentially the same as everyone else's — which is exactly why the useful signal is the pattern over time you pace by, not one reading. (ncbi.nlm.nih.gov)
What Welltory's chronic-pain data actually shows
Among Welltory users who self-report chronic pain (n = 1,151), compared with users who do not (n = 2,994), the pattern is not one dramatic broken number. It is a heavier overall load that mostly travels with other co-occurring conditions:
Users who self-report chronic pain report far more co-occurring conditions on average (median condition count ≈ 2.3 vs 0.6). Pain rarely arrives alone.
Self-reported markers like a heavy crash after effort (≈ 38% vs 18%), lower daily steps (≈ 6,671 vs 7,800/day), and brain fog are all raised — but on a like-for-like comparison within the same comorbidity level these gaps flatten out, so they appear to reflect the cluster of conditions that co-occur with chronic pain rather than chronic pain on its own.
Meanwhile a single morning HRV score, readiness/health score, resting heart rate, and recovery ratio barely move between the two groups.
The practical takeaway matches the treatment thesis: no single snapshot number reliably captures a person's pain load. A plan built around one "good enough" reading can miss the body you actually woke up in — the accumulated poor sleep, the extra errands, the flare that started two days ago, the comorbid fatigue, the nervous system that has learned to protect you too loudly. That is why pacing and self-management work with the trend and day-to-day pattern instead.
This is a reader data note, not a headline finding: none of these gaps survived like-for-like comparison, so they reflect the co-occurring cluster rather than chronic pain on its own.
How we measured it: n = 1,151 Welltory users who self-report chronic pain via an in-app survey, vs 2,994 users without it, all with wearable-quality data (Apple Watch / iPhone Health + Welltory), snapshot 2026-06 (see cohort.json). Metrics are per-user medians of daily wearable summaries and survey responses; every difference was re-checked within strata of self-reported condition count and either flattened (confounded) or was too small to be material. These are self-reported conditions selected by survey — a selector, not a clinical diagnosis, and the label's error rate is not measured — so figures describe this tracking population, not all people with chronic pain. All figures are reported as anonymized, aggregated data; no individual user is identifiable.
The honest starting point: chronic pain is common, disabling, and rarely "cured" by one thing
Chronic pain is not just "pain that lasts." "Chronic pain affects a substantial proportion of the global population and remains a leading cause of disability", and the same research is blunt about why a single fix is elusive: "Existing treatments largely target neuronal excitability and synaptic transmission, yet durable pain relief is uncommon and safety concerns, particularly those associated with opioids, persist". In the U.S., the scale is visible in national survey data: in 2023, 24.3% of adults reported chronic pain, and 8.5% reported high-impact chronic pain that frequently limited life or work activities. (cdc.gov)
That reframes the goal. Because no one intervention reliably switches pain off, effective care is layered and personalized: reduce the load, restore function and movement, and address the mind–body loop — with medication added by class when it helps. NINDS describes pain as shaped by biological, psychological, social, and environmental factors, which is why treatment is complex and individual; CDC’s 2022 opioid guideline also places exercise, physical therapy, psychological therapy, mindfulness-based approaches, and other noninvasive options inside chronic-pain care rather than treating medication as the whole plan. Modern research explicitly positions drugs as one part of a bigger plan, calling for "pragmatic integration into multimodal care". (ninds.nih.gov)
For chronic non-cancer pain, opioids are not a routine first-line answer: CDC 2022 says nonopioid therapies are preferred for subacute and chronic pain, and opioids should only be considered when expected benefits for pain and function are likely to outweigh risks for that individual. Do not start, stop, taper, or change opioid treatment without a qualified clinician. (cdc.gov)
If you're still trying to understand your pain — what it is, why it persists, and how "central sensitization" fits in — start with the broader [chronic pain guide](/chronic-pain/) and bring your clinician a written list of what limits you most.
Movement and physical therapy — the evidence-based backbone
For many long-term pain conditions, physical activity and physical therapy are a core pillar, not an optional extra. NICE recommends supervised exercise programs for chronic primary pain, and Cleveland Clinic describes chronic pain rehab as an individualized, interdisciplinary plan with a strong exercise focus to rebuild strength, endurance, and flexibility. The catch is how you move: the goal is graded, tolerable activity that rebuilds function, not proving you can push through pain. (nice.org.uk)
Start where you are and build by tolerance. Guided physical therapy, low-impact aerobic work, mobility practice, and gentle strengthening are common starting points because they can be scaled to your current capacity. A physical therapist looks at how you move, what flares you, what you avoid, and what you need your body to do in real life — then adjusts load and progression so your nervous system gets repeated “this is safe enough” signals instead of repeated threat signals. In chronic low back pain specifically, a Cochrane review found moderate-certainty evidence that exercise is probably more effective than no treatment, usual care, or placebo for pain, while functional gains tend to be smaller and depend on the person and program. (my.clevelandclinic.org)
Pain-science education changes outcomes. "Education is considered a foundational component of chronic pain treatment", and when people learn how pain works they shift how they engage with care: "Participants expanded their understanding of chronic pain from a biomedical model to a more integrated biopsychosocial perspective", which supported engaging with evidence-based, self-managed care. That matters because chronic pain is not just a “tissue damage meter.” It is shaped by nerves, immune signaling, sleep, stress chemistry, fear, memory, attention, and the body’s learned protection patterns — so education is not a lecture; it is part of treatment because it changes the meaning your brain assigns to movement. Pain neuroscience education is recognized in chronic musculoskeletal pain care as a strategy for helping people understand and work with the biopsychosocial parts of pain. (pubmed.ncbi.nlm.nih.gov)
Pacing beats boom-and-bust. For flares and for pain that overlaps with fatigue conditions, the modern framing is staying within a personal activity corridor rather than swinging between overexertion and collapse. Pacing is commonly described as balancing activity and rest so you can participate more consistently in meaningful activities; chronic pain research also notes that pacing is widely used but not one single standardized technique, so the details should fit your pattern, goals, and flare response. This is the direct bridge to tracking: when you can see what amount of walking, chores, work, stress, or poor sleep tends to precede a flare, you can adjust earlier instead of waiting until your body forces you to stop. See the data note above and the FAQ on tracking. (pubmed.ncbi.nlm.nih.gov)
⚠️ Safety: if your pain overlaps with ME/CFS or Long COVID and you experience post-exertional malaise — symptoms that crash 12 to 48 hours after physical, cognitive, or emotional effort — rigid “just exercise more” programs can backfire. CDC guidance for ME/CFS says PEM can last days or weeks, that pacing aims to prevent PEM flare-ups by balancing activity and rest, and that standard exercise recommendations for healthy people can substantially harm people with ME/CFS. The goal there is not forced conditioning; it is staying within limits, then cautiously adjusting only with a clinician who understands PEM. → see [ME/CFS treatment](/me-cfs/treatment/) and [fibromyalgia treatment](/fibromyalgia/treatment/). (cdc.gov)
Mind–body and psychological therapies (CBT, ACT, education)
Psychological therapy in chronic pain is not a way of saying “the pain is in your head.” Your pain is real. These therapies work because pain is processed by a nervous system that is also listening to threat, sleep loss, fear, stress hormones, attention, movement avoidance, and mood. When that system stays on high alert, pain can take up more space in the body and in daily life. Mind–body and psychological care gives you tools to lower that alarm and rebuild function, even when the pain does not disappear overnight.
Cognitive behavioral therapy (CBT) is one of the most established psychological approaches in chronic pain care. It helps you notice the pain–stress spiral — “this flare means I’m damaged,” “I can’t cope,” “movement will make everything worse” — and replace it with safer, more workable responses. That does not mean positive thinking. It means training your brain and body to respond to pain with less panic, less shutdown, and more choice. Reviews of guidelines find CBT recommended across chronic pain conditions, and Cochrane evidence includes CBT among the main psychological therapies studied for chronic pain, with benefits generally described in modest, function-focused terms rather than as a cure. (ncbi.nlm.nih.gov)
Acceptance and commitment therapy (ACT) takes a slightly different route. Instead of trying to argue pain away, ACT helps you make room for difficult sensations while moving toward what matters: walking the dog, parenting, work, intimacy, exercise, sleep routines, or simply leaving the house. The target is psychological flexibility — the ability to live with less avoidance and less struggle around pain. Systematic reviews report that ACT can improve pain acceptance, functioning, anxiety, depression, and related psychological outcomes, while effects on pain intensity are not the whole story and should not be oversold. (pubmed.ncbi.nlm.nih.gov)
This is why CBT, ACT, mindfulness-based skills, education, and behavioral pacing are often delivered inside multidisciplinary pain programs. Chronic pain rarely has one lever. A good program may combine movement, pacing, sleep work, nervous-system education, and psychological tools so your body gets the same message from several directions: you are not in immediate danger; you can move carefully; you can do more without crashing. (ncbi.nlm.nih.gov)
Lower-intensity tools can still matter. Therapeutic writing, for example, is not a replacement for clinical care, physical rehabilitation, or mental health treatment when you need it. But structured writing may help some people process fear, grief, anger, identity changes, and the daily load of living with pain. "Therapeutic writing may offer modest but meaningful psychological benefits for adults with chronic pain", best used as "a low-intensity adjunct within multidisciplinary pain management". (pmc.ncbi.nlm.nih.gov)
Education is foundational, too. Learning how pain works is not a “before treatment” lecture; it is part of treatment. When you understand that chronic pain can reflect a sensitized alarm system — not just ongoing tissue damage — flare-ups become less mysterious and less terrifying. That shift can make pacing, graded movement, CBT, ACT, sleep work, and self-monitoring easier to use consistently. A 2026 European Journal of Pain study describes education as a foundational component of chronic pain treatment, especially as programs move into more accessible online formats. (pubmed.ncbi.nlm.nih.gov)
Medications, by class — what they target (and who decides)
⚠️ HIGH-RISK block — class-level only. No doses, no schedules, no "best drug." Your clinician decides.
Because no single medicine cures chronic pain, medication decisions start with a narrower question: what is driving *your* pain pattern right now? Inflammation behaves differently from nerve pain. A sensitized nervous system behaves differently from a swollen joint. Sleep loss, low mood, flare fear, and deconditioning can all raise the volume on pain, too. That is why drugs are chosen by class, for a target, case by case — and layered onto the movement, pacing, and psychological backbone, not used instead of it. CDC’s 2022 opioid guideline puts the same principle plainly: for subacute and chronic pain, clinicians should maximize nonpharmacologic and nonopioid options when appropriate, and only consider opioids when expected benefits for pain and function outweigh risks. (cdc.gov)
| Medication class (examples) | What it targets in chronic pain | How it's used (clinician-decided) |
|---|---|---|
| Non-opioid analgesics / anti-inflammatories | These are aimed at baseline pain and pain with an inflammatory or musculoskeletal contributor — for example, when irritated tissue, joints, or local inflammation are part of the signal. They do not “reset” chronic pain by themselves, but they can sometimes make the pain load easier to work with. | Often considered before opioids when appropriate for the condition, but they are not automatically right for everyone. NSAIDs, for example, can carry gastrointestinal, kidney, and cardiovascular risks, so the agent, suitability, and monitoring are individualized by a clinician. class-level only; no dose, no self-medication (cdc.gov) |
| Antidepressant neuromodulators (e.g. SNRIs, tricyclics) | These are not used only “because pain is emotional.” They can act on pain-processing pathways — the body’s descending control systems that help turn pain signals up or down — and may be especially relevant when pain travels with poor sleep, distress, low mood, fibromyalgia-type symptoms, or neuropathic features. | Used at class level for specific pain and comorbidity targets. NICE says that if an antidepressant is offered for chronic primary pain, the discussion should cover possible effects on quality of life, pain, sleep, and psychological distress, even without a diagnosis of depression. A clinician decides the medicine, whether it fits your diagnosis, and how to monitor benefits and harms. class-level only; agent and dose decided by a clinician; not a mood-only or pain-only label (nice.org.uk) |
| Gabapentinoids (e.g. gabapentin, pregabalin) | These target overactive nerve-signaling patterns, especially when pain has a neuropathic quality — burning, shooting, electric, tingling, or hypersensitive-to-touch pain. They are not a general-purpose fix for every chronic pain condition. | Considered only when the pain type and diagnosis fit. NICE advises against initiating gabapentinoids for chronic primary pain except in a specific clinical-trial context for complex regional pain syndrome, while CDC notes they may be considered for certain neuropathic pain conditions and fibromyalgia-type contexts. Sedation and other safety issues mean clinician oversight is essential. class-level only; specific drug/dose decided by a clinician (nice.org.uk) |
| Opioids | These act on opioid receptors and can reduce pain signals, but in chronic non-cancer pain their role is limited because benefit often does not scale safely over time. Dependence, tolerance, withdrawal, overdose risk, and opioid-induced hyperalgesia can become part of the problem rather than the solution. | Not routine first-line for subacute or chronic pain. If they are ever used, the decision should be deliberate, monitored, tied to functional goals, and paired with an exit plan if benefits do not outweigh risks. Do not start, stop, taper, or change opioids without medical supervision. not first-line for chronic non-cancer pain; dependence & other risks; clinician-only decision; no dose (cdc.gov) |
Emerging / other approaches. Research is active on non-opioid and non-drug options — from neuromodulation to immune-targeted mechanisms — but the same reviews stress that these approaches belong inside comprehensive care, not outside it as a shortcut. Chronic pain is increasingly understood as needing "pragmatic integration into multimodal care". No single drug or device is a proven cure for chronic pain; anything new is a clinical decision with your physician. (pubmed.ncbi.nlm.nih.gov)
Opioids — the honest, careful section
Opioids deserve their own careful corner because many people with chronic pain search for them when they feel out of options, and because the risks are not vague or theoretical. For chronic non-cancer pain, they are not routine first-line treatment. The CDC’s 2022 guideline says nonopioid therapies are preferred for subacute and chronic pain, and that clinicians should maximize non-drug and nonopioid options first; opioids are considered only when expected benefits for pain and function are likely to outweigh the risks for that individual person. That is not the same as “opioids are never used.” It means they sit inside a cautious, clinician-led plan, not at the center of chronic pain care by default. (cdc.gov)
The reason for that caution is in the biology. Opioids can reduce pain signals, but the nervous system can adapt to them over time. As one review puts it, "Opioid analgesics are essential in the management of severe and chronic pain; however, their prolonged use is limited by the onset of analgesic tolerance and opioid-induced hyperalgesia". In plain language: the same medicine can gradually feel less effective, and in some people the pain system can become more sensitive rather than calmer. That possibility is one reason “just increasing” an opioid is not a simple or safe chronic-pain strategy. (pubmed.ncbi.nlm.nih.gov)
Deprescribing can also be part of care, but it is not abandonment and it is not something to do on your own. For some higher-risk groups, the literature notes that "Current guidelines recommend opioid deprescribing for high-risk populations". The CDC also warns against rapid tapering or abrupt discontinuation when opioids have been used long term, because the body may be physically dependent even when the medicine was taken as prescribed. If the risk–benefit balance changes, tapering is planned, paced, monitored, and adjusted by a clinician. (pubmed.ncbi.nlm.nih.gov)
The conversation matters as much as the prescription. If you have lived with pain for months or years, being told “we should reduce opioids” can feel like your pain is being dismissed. Good care should do the opposite: explain why chronic pain can persist through changes in the nervous system, validate that the pain is real, and make any opioid decision part of a broader plan for function, flares, sleep, mood, and safety. Qualitative work with chronic pain patients says it clearly: "education about the biopsychosocial nature of pain may provide a necessary foundation for communication around reducing opioid use" — but validation is what helps that conversation feel safe enough to have. (pmc.ncbi.nlm.nih.gov)
⚠️ Safety (HIGH-RISK, opioids): Never start, stop, combine, or change the dose of opioids or other pain medicines on your own. Opioids carry risks of dependence, tolerance, opioid-induced hyperalgesia, overdose, and dangerous interactions — especially with alcohol, benzodiazepines, sleep medicines, muscle relaxants, or other substances that slow the central nervous system. Any decision about opioids, including tapering, is made and supervised by a clinician. If you have severe shortness of breath, slow or shallow breathing, choking or gurgling sounds, extreme drowsiness, loss of consciousness, or a suspected overdose, seek emergency care immediately. (fda.gov)
How Welltory helps — and what it cannot do
The limit first: Welltory does not measure pain. Nothing does. Every pain scale in clinical use, including the McGill questionnaire, works by asking you — and pain scores are valid within one person over time, not between people.
What it can hold is the context around the pain, which is exactly what pacing needs. Chronic pain tracks load, and load is the thing memory reconstructs worst. A week later, "I think I overdid it Tuesday?" is a guess. A row of days with activity, sleep and resting heart rate on them is a record you can pace by.
Two honest caveats. These signals are non-specific — they move with stress, illness, alcohol and plain sleep loss just as readily as with a flare, so read the trend and not one morning. And a tracker cannot tell you whether today's rise is a flare or a bad night; that is a judgment, and it is yours and your clinician's.
Used that way it earns its place: not as a pain meter, but as the record that turns "it's been bad lately" into something an appointment can act on.
Managing flares and self-management
Flares are not proof that you “ruined” treatment. NICE defines a flare-up as a sudden, temporary worsening of symptoms — usually more intense day-to-day pain, and sometimes more fatigue, stiffness, lower function, or disease activity — and notes that flares can be unpredictable and vary in duration. The practical response is to ease the load without going completely still: shrink the task, take breaks sooner, choose gentler movement if you’ve been cleared to move, and use your pacing plan before your body forces you to stop. That’s what pacing is for — not pushing through, not resting forever, but balancing activity and rest so you can keep function and stay connected to meaningful routines. (nice.org.uk)
During a flare, protect the things that can turn the pain volume up or down: sleep, stress load, fear of movement, and tomorrow’s schedule. Gentle walking, mobility work, breathing, mindfulness, CBT- or ACT-style coping skills, heat or cold if they already help you, and a simpler version of your physical-therapy plan can all belong in a flare plan. They are not magic “natural remedies” for chronic back pain or any other chronic pain condition. They are low-burden tools that help your nervous system and muscles get through a high-signal period without adding more threat. Chronic pain care works best as a layered plan — education, self-management, physical activity or therapy, psychological skills, lifestyle changes, and clinician-selected medical options — because no single approach works for every person or every pain type. (ninds.nih.gov)
If a flare makes you want to start, stop, increase, taper, or combine pain medicines, pause and contact your clinician. Medication changes during a flare are a clinician’s call, especially if pain is different than usual, side effects appear, or you’re using prescribed pain treatment that needs monitoring. If the flare comes with red flags — new weakness or numbness, loss of bladder or bowel control, fever, chest pain, major injury, or pain that feels sharply different from your normal pattern — treat that as a reason to seek medical care rather than self-manage at home. (cdc.gov)
When chronic pain overlaps with other conditions
Chronic pain rarely travels alone. In Welltory’s self-reported cohort, people with chronic pain reported a median of about 2 other conditions — a useful signal, but not proof that pain caused those conditions or the other way around. The overlap is messy because pain lives in the nervous system, immune signaling, sleep, mood, movement, and stress physiology at the same time. That is why chronic pain often shows up beside fibromyalgia, ME/CFS, migraine, anxiety or depression, and sleep problems. NINDS describes chronic pain as a biopsychosocial experience and notes that depression, generalized anxiety disorder, PTSD, and sleep problems commonly co-occur with it. (ninds.nih.gov)
One shared mechanism is central sensitization: your pain system becomes more reactive, so signals that used to feel neutral or manageable can start feeling louder, sharper, or more widespread. This does not mean the pain is “all in your head.” It means the brain and spinal cord are part of the pain loop. NINDS describes peripheral and central sensitization as changes that make a person more sensitive to pain and other sensations, with signs like hyperalgesia and allodynia. Research also links central sensitization–type patterns with overlapping syndromes such as fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, chronic pelvic pain, and chronic daily headache. (ninds.nih.gov)
That overlap is exactly why care is usually multidisciplinary. A plan that only chases one label can miss the load your whole system is carrying. For chronic primary pain, NICE recommends a person-centered plan and supports supervised exercise or physical activity adapted to the person, plus pain-focused psychological therapies such as CBT or ACT when delivered by trained clinicians. CDC’s 2022 opioid guideline also emphasizes nonpharmacologic and nonopioid options for subacute and chronic pain, including exercise therapy, mindfulness-based approaches, CBT, and multidisciplinary rehabilitation depending on the condition. (nice.org.uk)
The practical plan often looks similar across labels, but the dose of life has to match the body you have today: reduce overload, pace activity, move by tolerance, protect sleep, use mind–body skills to calm threat signaling, and track what reliably worsens or steadies symptoms. If ME/CFS is part of the picture, this matters even more: post-exertional malaise means symptoms can flare after physical, mental, or emotional effort, so “push through it” can backfire. (cdc.gov) Medication decisions — including which class is appropriate, whether a medicine is worth continuing, and how to change it safely — belong with a qualified clinician who can weigh the pain condition, comorbidities, risks, and other treatments.
So if one clinician treats “fibromyalgia” and another treats “migraine” or “ME/CFS,” the day-to-day principles may still point in the same direction: lower the total strain on the nervous system, rebuild capacity slowly, and avoid single-fix promises. People do recover function, and flares can become less frightening and less disruptive. But there is no guaranteed “cure for central sensitization,” and a story like “I cured my chronic pain and migraines” may describe one person’s path — not a universal protocol. For related condition-specific plans, see [fibromyalgia treatment](/fibromyalgia/treatment/) and [ME/CFS treatment](/me-cfs/treatment/).
How to bring this up with your doctor
Chronic pain appointments go better when you arrive with a pattern rather than a description. "It's been bad lately" is hard to act on. Two weeks of notes is not.
Bring four things. A rough daily pain number, so the clinician can see the shape rather than the peak. What you did on the days it rose — chronic pain often tracks load, and the link is usually visible only in hindsight. How you slept, because poor sleep and higher pain feed each other in both directions. And what you have already tried, including what you stopped and why.
Ask three questions. What is my working diagnosis, and is this primary chronic pain or pain secondary to something else? That distinction changes the guideline that applies. What is the plan meant to improve — the pain number, or what I can do in a day? The second is usually the more honest target. And what should I do when a flare hits, specifically, so you have a plan before you need one.
If you were dismissed. Being told that the scans are clean is not the end of the conversation — it is a finding, and chronic primary pain is diagnosed precisely when pain persists without a structural explanation that accounts for it. Asking for a referral to a pain clinic or a physiotherapist experienced in persistent pain is reasonable. So is asking for the reasoning to be written into your notes.
How we made it
This article was drafted with support from AI tools, then edited, fact-checked and medically reviewed by the Welltory team before publication. We use AI to help organize evidence and improve clarity, but clinical claims, wording around treatment, and safety notes are reviewed by humans. See our Editorial & AI policy.
Data analysis by Jane Smorodnikova, co-founder of Welltory and the person who built the methodology behind how we read physiological data.
Written by Kseniia Iaroslavtseva.
Reviewed by Anna Elitzur — Medical Advisor & Mental Health Expert.
Any figures mentioned in this article are based on anonymized, aggregated data. They describe patterns across groups, not individual people, and no Welltory user can be identified from them.


Discounts for blog readers: up to 36% off
See what affects your energy, stress, sleep, and daily state with Welltory
This article is for educational purposes only and does not replace medical advice, diagnosis, or treatment. No single drug cures chronic pain; any medication class is prescribed and monitored by a qualified clinician. Opioids carry risks of dependence and are not a routine first-line treatment for chronic non-cancer pain. Do not start, stop, or change any treatment based on this page.
Was this helpful?
Ask AI for a summary of page
Written by Jane Smorodnikova
The founder and CEO of Welltory. A recognized tech leader with two Master's degrees and experience at MIT, she has scaled Welltory to over 17 million users.
Written by Kseniia Iaroslavtseva
Reviewed by Anna Elitzur
With her medical degree, Anna reviews Welltory's health content for medical accuracy and alignment with current clinical guidelines and research.
References
- Zhai Y, Ma J, Wang S, et al. (2026), Frontiers in Immunology — “Targeting neuroimmune pathways in chronic pain: clinical insights and immunotherapeutic prospects”; chronic pain as a major disability burden, durable relief uncommon, opioid safety concerns, and immune-targeted approaches needing pragmatic integration into multimodal care. /. https://pubmed.ncbi.nlm.nih.gov/42099650/
- McCarron M, Agnew F, Briggs C, et al. (2026), European Journal of Pain — “Pain Retrained: Participant Perspectives of an Online, Interdisciplinary Chronic Pain Education Programme”; education as foundational to chronic pain treatment and movement from biomedical to biopsychosocial understanding/self-management. https://pubmed.ncbi.nlm.nih.gov/41609480/
- Salikka T, Kylmä J, Fröjd S. (2026), European Journal of Pain — “Therapeutic Writing Interventions for Adults With Chronic Pain”; therapeutic writing as a modest, low-intensity adjunct within multidisciplinary pain management. https://pmc.ncbi.nlm.nih.gov/articles/PMC12910190/
- Qin F, Wang Q, Abdi S, Li L. (2026), Biology — “Synaptic Plasticity as a Mechanism of Opioid Tolerance and Hyperalgesia”; prolonged opioid use limited by analgesic tolerance and opioid-induced hyperalgesia. https://pmc.ncbi.nlm.nih.gov/articles/PMC13113697/
- Opioid deprescribing cohort study (2026), Clinical Pharmacology & Therapeutics — “Opioid Deprescribing Rates and Predictors Among Medicare Enrollees With Cirrhosis and Chronic Pain”; guidelines recommend opioid deprescribing for high-risk populations, with tapering/discontinuation data in Medicare enrollees. https://pubmed.ncbi.nlm.nih.gov/41630579/
- Amin JR, Ekelin E, Nilsing Strid E, Boersma K, Bergbom S. (2026), Scandinavian Journal of Primary Health Care — “Expectations and communication in opioid pain management”; patient experience of opioid pain management and the importance of validation, expectations, and communication. https://pmc.ncbi.nlm.nih.gov/articles/PMC12833907/
- CDC (2022) — “CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022”; nonopioid therapies preferred for subacute and chronic pain, opioids not first-line or routine therapy, and rapid tapering/abrupt discontinuation discouraged. CDC MMWR. https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm
- NICE NG193 (2021) — “Chronic pain (primary and secondary) in over 16s”; person-centered assessment, supervised exercise, ACT/CBT for chronic primary pain, antidepressant discussion framing, and medicines not to initiate for chronic primary pain including opioids and gabapentinoids except specified trial context. NICE recommendations. https://www.nice.org.uk/guidance/ng193/chapter/Recommendations
- NINDS — Pain — chronic pain as a biopsychosocial experience, central and peripheral sensitization, psychological and social factors, co-occurring sleep/mood issues, and individualized evaluation/treatment. NINDS. https://www.ninds.nih.gov/health-information/disorders/pain
- IASP — Chronic Pain — multimodal/biopsychosocial chronic-pain care model
- CDC/NCHS Data Brief No. 518 (2024) — “Chronic Pain and High-impact Chronic Pain in U.S. Adults, 2023”; 24.3% chronic pain and 8.5% high-impact chronic pain in U.S. adults in 2023. CDC NCHS. https://www.cdc.gov/nchs/products/databriefs/db518.htm
- Hayden JA, Ellis J, Ogilvie R, Malmivaara A, van Tulder MW. (2021), Cochrane Database of Systematic Reviews — “Exercise therapy for chronic low back pain”; moderate-certainty evidence that exercise is probably effective for pain compared with no treatment/usual care/placebo, with smaller functional gains. https://pmc.ncbi.nlm.nih.gov/articles/PMC8477273/
- Williams ACDC, Fisher E, Hearn L, Eccleston C. (2020), Cochrane Database of Systematic Reviews — “Psychological therapies for the management of chronic pain (excluding headache) in adults”; CBT, ACT, and related psychological therapies for chronic pain. / Cochrane abstract PDF. https://pubmed.ncbi.nlm.nih.gov/32794606/
- Hughes LS, Clark J, Colclough JA, Dale E, McMillan D. (2017), The Clinical Journal of Pain — “Acceptance and Commitment Therapy (ACT) for Chronic Pain”; ACT associated with improvements in pain acceptance, psychological flexibility, functioning, anxiety, and depression, with pain intensity not the only outcome. https://pubmed.ncbi.nlm.nih.gov/27479642/
- Jamieson-Lega K, Berry R, Brown CA. (2013), Pain Research and Management — “Pacing: a concept analysis of the chronic pain intervention”; pacing as active self-management balancing activity and rest for function and meaningful participation. /. https://pubmed.ncbi.nlm.nih.gov/23717825/
- CDC ME/CFS clinical care (2024) — “Strategies to Prevent Worsening of Symptoms”; PEM timing, pacing/activity management, avoiding push-crash cycles, and warning that standard exercise recommendations can substantially harm people with ME/CFS. CDC. https://www.cdc.gov/me-cfs/hcp/clinical-care/treating-the-most-disruptive-symptoms-first-and-preventing-worsening-of-symptoms.html
- FDA Drug Safety Communication (2023) — updates to opioid pain medicine prescribing information, respiratory-depression warnings, opioid-induced hyperalgesia, and risks with benzodiazepines, alcohol, or other CNS depressants. FDA. https://www.fda.gov/drugs/drug-safety-communications/fda-updates-prescribing-information-all-opioid-pain-medicines-provide-additional-guidance-safe-use
- FDA safety measures for opioids and benzodiazepines — boxed-warning context for serious risks when opioids are combined with benzodiazepines or other CNS depressants, including alcohol. FDA. https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and
- Stretanski MF, Kopitnik NL, Matha A, Conermann T. (2025 update), StatPearls / NCBI Bookshelf — “Chronic Pain”; chronic pain overview, multimodal/interprofessional management, function-focused assessment, and medication-class context. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/sites/books/NBK553030/
- Cleveland Clinic — Chronic Pain Rehabilitation — chronic pain rehabilitation as interdisciplinary medical, physical, and psychological care with individualized treatment and exercise focus. Cleveland Clinic. https://my.clevelandclinic.org/departments/rehabilitation/services/chronic-pain


-2.jpg)




